A detailed history of Mc Donough Capital Management, Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Mc Donough Capital Management, Inc holds 611 shares of LLY stock, worth $467,237. This represents 0.37% of its overall portfolio holdings.

Number of Shares
611
Previous 611 -0.0%
Holding current value
$467,237
Previous $553,000 2.17%
% of portfolio
0.37%
Previous 0.4%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$724.87 - $909.04 $10,148 - $12,726
14 Added 2.35%
611 $553,000
Q1 2024

May 15, 2024

BUY
$592.2 - $792.28 $353,543 - $472,991
597 New
597 $464,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $727B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Mc Donough Capital Management, Inc Portfolio

Follow Mc Donough Capital Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Donough Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mc Donough Capital Management, Inc with notifications on news.